{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:05:57Z","timestamp":1782957957420,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.dsx.2016.01.034","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T03:34:45Z","timestamp":1452828885000},"page":"S77-S81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"S1","title":["Correlation between non-alcoholic fatty liver disease (NAFLD) and dyslipidemia in type 2 diabetes"],"prefix":"10.1016","volume":"10","author":[{"given":"Saini","family":"Krishan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.dsx.2016.01.034_bib0180","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1665-2681(19)30879-8","article-title":"The prevalence of nonalcoholic fatty liver disease in the Americas","volume":"13","author":"Lopez-velazquez","year":"2014","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.dsx.2016.01.034_bib0185","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo clinic experience with an hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.dsx.2016.01.034_bib0190","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0002-9343(79)90740-X","article-title":"Fatty liver hepatitis and cirrhosis in obese patients","volume":"67","author":"Adler","year":"1979","journal-title":"Am J Med"},{"key":"10.1016\/j.dsx.2016.01.034_bib0195","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01296926","article-title":"Fasting in obesity: another cause of liver injury with alcoholic hyaline?","volume":"27","author":"Capron","year":"1982","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dsx.2016.01.034_bib0200","first-page":"650","article-title":"Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis","volume":"82","author":"Itoh","year":"1987","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dsx.2016.01.034_bib0205","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/0016-5085(88)90183-7","article-title":"Alcohol-like liver disease in non-alcoholics: a clinical and histologic comparison with alcohol-induced liver disease","volume":"95","author":"Diehl","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dsx.2016.01.034_bib0210","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/0046-8177(89)90249-9","article-title":"Non-alcoholic steatohepatitis: a study of 49 patients","volume":"20","author":"Lee","year":"1989","journal-title":"Hum Pathol"},{"key":"10.1016\/j.dsx.2016.01.034_bib0215","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.1840120505","article-title":"Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors","volume":"12","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.dsx.2016.01.034_bib0220","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/hep.1840110114","article-title":"The natural history of non-alcoholic steatohepatitis: a follow-up study of 42 patients for up to 21 years","volume":"11","author":"Powell","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.dsx.2016.01.034_bib0225","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1440-1746.1991.tb00915.x","article-title":"Non-alcoholic steatohepatitis: impaired antipyrine metabolism and hypertriglyceridaemia may be clues to its pathogenesis","volume":"6","author":"Fiatarone","year":"1991","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.dsx.2016.01.034_bib0230","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0016-5085(94)90235-6","article-title":"Non-alcoholic steatohepatitis: an expanded clinical entity","volume":"107","author":"Bacon","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dsx.2016.01.034_bib0235","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1053\/jhep.2002.31551","article-title":"NASH: from liver diseases to metabolic disorders and back to clinical hepatology","volume":"35","author":"Marchesini","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.dsx.2016.01.034_bib0240","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dsx.2016.01.034_bib0245","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Non-alcoholic fatty liver disease","volume":"16","author":"Angulo","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dsx.2016.01.034_bib0250","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1053\/jhep.2002.32483","article-title":"Non-alcoholic fatty liver disease: an agenda for clinical research","volume":"35","author":"Younossi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.dsx.2016.01.034_bib0255","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1046\/j.1440-1746.2003.02989.x","article-title":"Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region","volume":"18","author":"Farrell","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dsx.2016.01.034_bib0260","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Non-alcoholic steatohepatitis: summary of an AASLD single topic conference","volume":"37","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.dsx.2016.01.034_bib0265","article-title":"Preventing and managing the global epidemic: report of a WHO consultation","volume":"vol. 894","author":"World Health Organization","year":"2000"},{"key":"10.1016\/j.dsx.2016.01.034_bib0270","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jama.289.1.76","article-title":"Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001","volume":"289","author":"Mokdad","year":"2003","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.dsx.2016.01.034_bib0275","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1210\/jcem.84.5.5661","article-title":"Liver pathology and the metabolic syndrome X in severe obesity","volume":"84","author":"Marceau","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2016.01.034_bib0280","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0016-5085(00)70364-7","article-title":"Liver fibrosis in overweight patients","volume":"118","author":"Ratziu","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dsx.2016.01.034_bib0285","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2001.25540","article-title":"Non-alcoholic fatty liver disease: predictors of non-alcoholic steatohepatitis and liver fibrosis in the severely obese","volume":"121","author":"Dixon","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dsx.2016.01.034_bib0290","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/jhep.2002.30690","article-title":"Non-alcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association","volume":"35","author":"Pagano","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.dsx.2016.01.034_bib0295","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.1840120505","article-title":"Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors","volume":"12","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.dsx.2016.01.034_bib0300","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2001-12925","article-title":"Non-alcoholic steatohepatitis: definition and pathology","volume":"21","author":"Brunt","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dsx.2016.01.034_bib0305","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.MP.0000042420.21088.C7","article-title":"Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease","volume":"16","author":"Brunt","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.dsx.2016.01.034_bib0310","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/hep.1840220616","article-title":"The natural history of non-alcoholic fatty liver: a follow-up study","volume":"22","author":"Teli","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.dsx.2016.01.034_bib0315","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/hep.510290401","article-title":"Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis","volume":"29","author":"Hourigan","year":"1999","journal-title":"Hepatology"},{"issue":"September\u2013December","key":"10.1016\/j.dsx.2016.01.034_bib0320","first-page":"188","article-title":"Association of non alcoholic fatty liver with type 2 diabetes mellitus","author":"Luxmi","year":"2008","journal-title":"JLUMHS"},{"issue":"5","key":"10.1016\/j.dsx.2016.01.034_bib0325","first-page":"156","article-title":"Dyslipidemia in patients with nonalcoholic fatty liver disease","author":"chatrath","year":"1999","journal-title":"Pubmad"},{"issue":"4","key":"10.1016\/j.dsx.2016.01.034_bib0330","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2036.2006.03021.x","article-title":"Statins for non-alcoholic fatty liver disease: a new indication?","volume":"24","author":"Liberopoulos","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.dsx.2016.01.034_bib0335","first-page":"19","article-title":"Non-alcoholic fatty liver disease and the statins treatment","volume":"50","author":"Alina Dima","year":"2012","journal-title":"Rom J Intern Med"},{"key":"10.1016\/j.dsx.2016.01.034_bib0350","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3797\/scipharm.1104-21","article-title":"Type 2 diabetes mellitus-induced hyperglycemia in patients with NAFLD and normal LFTs: relationship to lipid profile, oxidative stress and pro-inflammatory cytokines","volume":"79","author":"Shams","year":"2011","journal-title":"Sci Pharm"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402115300473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402115300473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T04:13:22Z","timestamp":1748751202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402115300473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1871402115300473"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2016.01.034","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between non-alcoholic fatty liver disease (NAFLD) and dyslipidemia in type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2016.01.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}